Autres langues Mineralys Therapeutics, Inc.

Actions

MLYS

US6031701013

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 21/06/2024			Varia. 5j.	Varia. 1 janv.
12,04 ^USD	+2,82%		-4,29%	+40,00%

20/06	Un initié de Mineralys Therapeutics a vendu des actions pour une valeur de 592 022 $, selon un récent dépôt auprès de la SEC	MT
14/06	Mineralys Therapeutics, Inc. annonce des changements au sein de son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Mineralys Therapeutics Insider Sold Shares Worth $592,022, According to a Recent SEC Filing	20/06
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors	14/06
Mineralys Therapeutics, Inc. Announces Changes to its Board	14/06
Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing	13/06
Mineralys Therapeutics : Corporate Overview June 2024	10/06
Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	03/06
Mineralys Therapeutics : Corporate Overview May 2024	13/05
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05
Mineralys Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference	06/05
Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024	02/05
Mineralys Therapeutics, Inc. Announces Alexander Asam Informs That His Decision Not to Stand for Re-Election to the Board	04/04
Mineralys Therapeutics Files Mixed-Securities Shelf Registration	21/03
Mineralys Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Mineralys Therapeutics : Corporate Overview March 2024	21/03
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	21/03
Mineralys Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
North American Morning Briefing : Investors -2-	21/03
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024	13/03
Sector Update: Health Care Stocks Ease in Late Afternoon	08/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Mineralys Therapeutics, Inc.

Actions

MLYS

US6031701013

Autres langues

Filtres